A judge sentenced a 35-year-old Kansas City man to 20 years in prison on Tuesday fo r a fatal shooting in 2024, Jackson ...

If 2023 was the year of shock and 2024 was the year of experimentation, 2025 marks the moment the corporate world finally accepted that artificial intelligence is not just a novelty—it is the new ...

The Taliban forced a 13-year-old boy to carry out a public execution, with 80,000 people packing a sports stadium to watch the young teen shoot the man who murdered 13 members of his family. Video ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

GameSpot may get a commission from retail offers. Earlier this month, Call of Duty: Black Ops 7 players called out the apparent use of AI in the game, especially the "Ghibli-style" Calling Cards.

Call of Duty Black Ops 7 is the latest high-profile game to confirm that it uses generative AI for some of its in-game assets, according to a disclosure on its Steam page. After similar disclosures ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins. Recursion'a lack of clinical ...

Spam and scam calls are some of the most annoying things we all have to deal with when it comes to our phones. Apple’s iOS 26 update takes a firm step toward solving this problem with Call Screening, ...